Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae-Reference-Cited by-同舟云学术

Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae

Published:2023-07 Issue:3 Volume:106 Page:115955
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Zhu Qiongfang,Xu Jie,Chen Xu,Ren Yalu,Zhao Lina

Funder

Jiangsu Province Natural Science Foundation

Pfizer Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study;Wang;Lancet Infect Dis,2022

2. Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection;Kim;J Antimicrob Chemother,2019

3. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013

4. Evolutionary and genomic insights into clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance;Knight;mBio,2019

5. Klebsiella pneumoniae ST258 is a hybrid strain;Chen;mBio,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Device-Associated Biofilm Infections and Multidrug-Resistant Pathogens;Pathogens;2024-05-08

2. Susceptibility Patterns in Staphylococcus and Klebsiella Causing Nosocomial Infections upon Treatment with E-Anethole-Rich Essential Oil from Clausena anisata;Drugs and Drug Candidates;2024-03-01

3. Microbiology and Clinical Outcome of Bloodstream Infections in Patients After Hematopoietic Stem Cell Transplantation;Infection and Drug Resistance;2023-08